Dr. Serge Jurasunas shares his Prostate Cancer Protocol in this paper, explaining the nature and treatment of Prostate Cancer from a Naturopathic Oncology Perspective. Professor Jurasunas is located in Lisbon Portugal and has lectured worldwide throughout his 50 years as a clinician. He explains what can be done about the #1 cause of death in males even before lung cancer and what can be done, from the new perspective of Naturopathic Oncology.He offers an example, explains diagnostic procedures with Molecular markers and addresses detox, supplements and treatment. Further information may be found in his new book, Health and Disease Begin in the Colon" and in his Blog: Naturopathiconcology.blogspot.com .

1. Protocol for the Treatment of Prostate Cancer
Dr. Serge Jurasunas
Professor of Naturopathic Oncology
Serge Jurasunas is an internationally well known figure and pioneer in
Naturopathic medicine, iridology, nutrition, complementary oncology, live
blood analysis (LBA) with 50 years of practice and experience in treating
chronic and degenerative disease and cancer. At the same time he
developed several innovative therapies. By studying both conventional
oncology and alternative medical science he has better understood the
advantages and failures of what we can expect from both perspectives.
Over the past decades he directed several clinics treating patients coming
from many countries but also has welcomed many doctors and physicians
coming to learn about his methods of cancer treatment. Today he both
teaches and collaborates with oncologists, medical doctors and researchers,
inviting them to join in and share mutual experience and knowledge and to
proliferate CAM methods both to practitioners and the public.
Lectures on Complementary Oncology
The work of professor Serge Jurasunas has become well known around
the world after having traveled and lectured in 40 countries in the field of
New Avenues of Cancer Treatment. He has attracted the interest of
Universities and was invited by the University of Vilnius (Lithuania)
Faculty of Medicine to deliver a seminar on “New Avenues and Treatment
in Oncology”, with a audience of about 300 doctors, oncologists,
immunologists, a rare privilege to introduce alternative cancer treatment
with the presentation of clinical cases to a Faculty of Medicine.
More recently he delivered a lecture on Molecular Markers in Cancer
Diagnostics and Therapy at the 2th International Congress on
Complementary Oncology in Munich, invited by the German Society of
Oncology.

2. The Molecular Basis of Cancer
New Paradigm
Serge Jurasunas is now deeply involved in the research and clinical
application of molecular markers, tumor suppressor genes and oncogenes
associated with cancer initiation, promotion and cancer development,
having spent about 10 years in the study and clinical application of
molecular markers testing with cancer patients before and after treatment,
with follow up, over periods lasting up to 4 years.
This approach facilitates better understanding of the genetic mechanism in
the disease of cancer, to check on resistant cancer cells, to make a
prognostic for each patient as well as customized selection of dietary
agents and other anticancer agents according to individual results. This
affirms the great advantage of personalized medicine that seems to be a
better response to cancer treatment since no two patients have the same
tumor suppressors and oncogene activity and therefore may have a good or

3. poor result with chemotherapyradiation. Also it permits us to predict
disease recurrence which is one of the failures of medicine. Correct
assessment is the first and most crucial step in the evaluation of the patient
with prostate cancer, however the modern conventional diagnosis that
includes laboratory testing and imaging, bone scan or other alternative
system is far from complete and does not provide a real basis for the
molecular gene aspect.
Publication of a Paper on Molecular Markers
Professor Serge Jurasunas is a frequent contributor to the Townsend Letter,
The Examiner of Alternative Medicine (USA) , having written articles on
cancer disease, clinical cases and molecular markers. The last article was,
“The Molecular Basis of Prostate Cancer and Targeting Therapies”, to be
published in the special Cancer Issue of August/September 2017, available
on request after publication.
“New Theories and Advances in Cancer Treatment”, is also available
from Slideshare. This article offers a wide range of details about prostate
cancer and the implication of tumor suppressor genes and oncogenes,
along with complete details about the effect of each anticancer agent or
dietary agent. It both documents and explains about what a patient can
really expect from conventional medicine, surgery, chemotherapy,
radiation or hormonotherapy. I offer further information on what to expect
from our protocol on prostate cancer which we have defined over the
years and that has demonstrated efficiency even with advanced cases of
prostate cancer with bone metastases.

4. Prostate Cancer
Disease States
Prostate cancer has become the #1 killer in men, even now before lung
cancer. When prostate cancer is diagnosed in about 50% of these cases it
can be expected that the disease will progress to an incurable stage. While
it is true that most prostate cancers are unsymptomatic and slow growing,
one third of the cases are more aggressive and fast developing. Prostate
metastases spreads relatively quickly to other parts of the body,
particularly lymph nodes, rectum, bones and brain. Hypoxia occurs in 30%
or 40% of prostate cancers which in turn increases angiogenic factors and
upregulates the P53 tumor suppressor gene that triggers apoptosis or the
death of cancer cells.
Conventional treatment includes a combination of surgery, chemotherapy,

5. radiation, hormonotherapy that may be effective for localized disease but
there is no effective treatment strategy for metastasized prostate cancer
which remains painful and incurable. Despite advances in local treatment,
approximately 25% of radically treated patients will develop disease
progression and 10% to 20% of the cases present at primary diagnostic
develop bone metastases. Chemotherapy could only extend the lives of
patients by months or few years at most.
Metastatic Prostate Cancer with Bone Metastases
One year survival: 87%
Five year survival: 56%
Metastatic Prostate cancer with Bone and Skeletal
Involvement
One year survival: 40%
Five year survival: less than 1%
What Can be Done to Improve this Situation
Therefore prostate cancer must be treated immediately in the beginning
with a complementary approach to avoid the spread of metastases in the
body. Many cases are hormone refractory, meaning they don't respond any
more neither to hormonal therapy and more often than not to
chemotherapy or radiation leaving the patient without solution. Secondly
advanced prostate cancer with bone and skeleton metastases no longer
benefits from chemotherapy and needs some alternative solution. As
explained in my document, “Integrative Cancer, New Theories and
Advances in Treatment”, more chemotherapy renders cancer cells more
resistant to destruction by apoptosis and contributes to making the disease
even worse, weakening more the patient. Also see in my new blog:
Https://naturopathiconcology.blogspot.com my new posting: "WHAT IS
CANCER". This may better explain the mechanism of the disease and

6. how to handle the patient. The article focuses on a new strategy of
anticancer treatment based on new rediscoveries of science concerning the
metabolic aspects of the disease according to the past research of Otto
Warburg on cellular respiration.
Cancer Cells are Tested for Genetic Markers
68 Year Old Patient
As an example in one non cancer patient, the husband of a women I was
treating for breast recurrence, a very nervous man (see the test above) we
detected a very high expressed survivin at 51.548 ul/ml of plasma. He was
lucky that the Bax gene expression was highly active at 81,699 units/ml of
plasma, where apoptosis was really functioning via this channel as a
defense to kill as many cancer cells as possible, but further showing that it
was already a tumor condition.
In fact with our treatment the second test showed that survivin gene

7. expression dramatically decreased to 105 units/ml of plasma. It was really
a performance decreasing this level using a combination of dietary agents.
However we had done the Tumor Marker-2-Pyruvate Kinase (TM-2-
Pyruvate Kinase) activity (unfortunately not at the first test) that really
showed a very high metabolic tumor activity, 142 units/ml of plasma. This
could have been higher before and decreased since I saw the case as high
as 290 units/ml of plasma or even 350 units/ml of plasma.(5-15 units is the
reference.)
Now the TM-2-PK activity decreased to 49.2 units/ml of plasma which is
excellent and survivin gene expression to 30 units/ml of plasma. So we
had the following: 51.548 - 105 – 30 units/ ml of plasma.
Later on the patient was finally diagnosed with a prostate tumor and
scheduled for surgery but in the meantime he kept taking our treatment
regimen and when he came into the hospital, during the surgery the
surgeon found no trace of a tumor. This is a true story. Another case of
advanced prostate cancer with bone metastasis.
In our clinic, cancer patients are tested for genetic markers such as the
P53 tumor suppressor gene known as the guardian of our genome. P53
mutation or defects appear necessary in cancer development, growth and
invasion. We look at Bax, an proapoptotic gene, BcL2, survivin, P21,
VEGF and others. Some oncogenes and inhibitors of apoptosis such the
BcL2 and survivin are usually overexpressed in prostate cancer increasing
the resistance of cancer cells. The ratio BcL2/Bax determines the quantity
of cancer cells destroyed through apoptosis. Survivin is a inhibitor of
apoptosis that can be detected only in cancer tissue. Meaning you can
detect the disease even before laboratory test. As an example in one non
cancer patient we detected a very high expressed survivin of 54.560 ul/ml
of plasma while the reference range is10 ul/ml meaning it was already a
advanced tumor but the patient didn't know about it. Another case of
advanced prostate cancer with bone metastasis had a PSA at 680 ng/ml,
very poor condition and our blood testing showed a very high survivin
activity of 24210 ul/ml of plasma and mutated P53.
After our treatment survivin dramatically decreased to 8 ul/ml of plasma
and we reversed the P53 mutation to a normal protein although with low
activity while PSA after one month decreased to 380 ng/ml and later on to
54 ng/ml. Such testing allows for individual and personalized treatment

8. base on the results of the test and using selected dietary agents,
phytotherapy, orthomolecular medicine and other anticancer agents
appropriate to prostate cancer cells that in turn increase apoptosis, inhibit
angiogenesis, increase immune defense and shoot down tumor growth.
Thanks to the research done by Prof. Serge Jurasunas who devoted
considerable time in scientific investigation and work to develop new
formulas like a curcumin in liquid with a very high absorption rate in his
own pharmaceutical laboratory.
Serge Jurasunas' Natural Medicine
For years Serge Jurasunas has accumulated enough clinical experience and
knowledge working with over 150,000 patients using all kinds of diet,
therapies from different sources enabling him to build his own Natural
Medicine Therapy. In relation to cancer treatment, Professor Serge
Jurasunas' methodology made a bridge between Naturopathic medicine
and Molecular medicine which permits treating the disease and the whole
body simultaneously. We know that some natural foods can change gene
expression and that many dietary agents like curcumin for instance can
target several mechanisms associated with cancer development and cancer
growth. Over the past decades Serge Jurasunas has researched a number
of dietary agents to see how they can modified tumor suppressor genes and
oncogenes after performing molecular markers testing. After several years
of observation with several hundred cancer cases he began to select some
dietary agents and other anticancer compounds that work in synergy and
offer better results leading some patients to complete remission or life span
extension, even when the disease was far advanced. These include
curcumin, resveratrol, genistein, pomegranate, Betacyanin (red beet) green
and black propolis, chorella extract, fish peptides, thymus extract, ginseng
extract, Omega3 and selenium.
Of course in our clinic we handle all types and grades of cancer and that
include prostate cancer along with most cases with bone and skeleton
metastases, ranging from a low to high PSA level that can be over 1200
ulml.

9. Between 5/2006 to 6/2007 PSA Declines from 1260 to 1.58
As an example we have the case of a 73 year old man diagnosed in
September, 2005 with a prostate cancer with metastases, disseminated
throughout the skeleton. In May, 2006 he came to me in bad physical
condition. PSA at 1260, no surgery, chemotherapy or radiation was
suggested by doctors. Only a hormonal therapy but without visible result.
After 4 months of our treatment the patient considerably improved
physically and feel happy. PSA decreased to 328 and after 8 months to 58
and finally to 2.8 and 1.58 after one year. After 6 months 50% of the bone
metastases was eliminated and after one year total elimination. The patient
is in remission with a good quality of life. Other cases are available on
www.sergejurasunas.com , include a taxi driver also with an advanced
prostate cancer who with no conventional treatment was cured after one
year, free from all the skeletal metastases. We followed him for more than
a 10 year period.
New Protocol for Prostate Cancer
Recently Serge Jurasunas has defined a new treatment for prostate cancer

10. by including new anticancer agents that he had researched and tested for a
period of 2 years, obtaining remarkable results confirmed by molecular
markers testing on patients before, during and after treatment. It also
showed a decreased PSA level and either reduction or elimination of tumor
and bone metastases. But some other anti-cancer agents have been utilized
for nearly 30 years for different types of cancer. Many results from clinical
cases were published over the past 18 years in the Townsend Letter, The
Examiner of Alternative Medicine (USA).
How to Approach Prostate Cancer
Cancer must be approached in several directions at same time that include
the following process which is considered as an important Hallmark of
Cancer.
Diagnostic and prognostic Factors
1. Apoptosis (One's own killing of cancer cells)
2. Angiogenesis (VEGF FGF)
3. Tumor suppressor (TGFB, cMyc, P53)
4. Oncogenes (BcL2 Survivin)
5. Inflammation (NF Kappa B, Cox2)
6. Immune modulation (NK cells Dendritic cells, T cells, B cells,
Macrophages)

11. Other factors can include blood parameters such as anemia, candida
growth, balancing the microbiome and strengthening the nervous system
since there is a relationship between the nervous system and the activation
of the Natural Killer Cells (N.K.Cells).
Suggested Protocol
This protocol is adapted to respond to the 6 Hallmarks of Cancer and has
shown efficacy in targeting the oncogene BcL2 and the inhibitor of
apoptosis survivin, both overexpressed in prostate cancer and responsible
for cancer cell resistance to chemotherapy and radiation.
Tegaran: Made from fermented soy that contains phytic acid, protease
inhibitors, saponins,phytosterols and genistein, that all in vitro and in vivo
tests and clinical studies have confirmed the positive effects of the
ingredients of the fermented soy extract in therapeutic approaches for
adjuvant treatment of solid tumor. Tegaran targets most of the molecular
aspect of cancer development and growth including apoptosis,
angiogenesis, immune system, inflammation and drug resistance.
Curcumin: An important dietary agent that acts by blocking the different
stage of cancer and inhibiting malignant cell proliferation during the
promotion and progression of prostate cancer. Curcumin acts on most of
the genes implicated in cancer. In prostate cancer curcumin has shown
efficacy to increase the destruction of cancer cells by halting the cell cycle
phase at G2 or M and sensitizes tumor cells to various antineoplasic
agents. Curcumin targets the oncogene BcL2 and survivin and increasing
P53 function, therefore triggering apoptosis and decreasing resistance of
cancer cells to chemotherapy and radiation. It's important to note
curcumin inhibits NF Kappa B, an inflammatory mediator that stimulates
most of the mechanisms associated with tumor growth, progression and
resistance to anticancer drugs. Curcumin is difficult to absorb through the
intestine and cells. This is why Serge Jurasunas developed a new formula
of liquid curcumin that is rapidly absorbed by the intestine and the cells,
which is manufactured in his own Pharmaceutical Laboratory in Portugal.

12. Biobran (Biological Response Modifier)
We now have used biobran for over 2 decades, an important
immunomodulator with anticancer properties. Biobran is a arabinoxylan
compound extracted out of rice bran cultivated on shitake enzyme and has
shown to have dramatic effects on our front line soldiers in the immune
system that work against cancer. It includes NK cells, dendritic cells and
macrophages. NK cells play an important function in the primary host
defense against cancer where defective NK cells function is associated
with various malignancies. Most cancer patients have a defective immune
system functioning from 0% to 30% compared to a healthy person. The
NK cells are here but not activated to release their toxic enzymes to
destroy cancer cells through apoptosis cellular activity, which subsequently
is increased 60% after 2 weeks with a daily dose of 2gr of Biobran. Then if
you continue you can achieve up to 200% and 300% NK cell number and
activity. Biobran has demonstrated efficacy to kill cancer cells either by
apoptosis or lysis and has a dramatic effect on prostate cancer especially
when prescribed in synergy with curcumin. Biobran Mgn3 is much more
powerful than any other arabynoxylan or mushroom extract found on the
market. We also found a synergistic effect when using both curcumin and
Biobran Mgn3 on apoptosis and tumor inhibition. Biobran Mgn3 and
curcumin modulate BcL2/Bax ratio by up-regulating the Bax gene and
down regulating the BcL2 oncogene, therefore increasing the death of
cancer cells through apoptosis and of course it increases the effectiveness
of chemotherapy. Even alone Biobran/Mgn3 and curcumin can reduce
tumor size. My new conference presentation that will be delivered on June
2017 at the 5th International Workshop Biobran in Krakow, Poland, will
fully explain the synergistic effect of these 2 compounds along with
several cases of cancer patients including Prostate cancer, using this
protocol. The lecture, “A New Modern Way to Approach Cancer” will be
available on slideshare. (or contact the author)
Prae Cell
This is a formula especially developed for prostate cancer that contains
fermented soy (same formula as Tegaran), lycopene from tomatoes, zinc,
selenium, vitamin D3 which is particularly efficient to treat prostate
cancer.

13. Detoxification
Detoxification is also a very important step in treating any disease,
especially cancer. Most people are intoxicated from bad dietary style,
excess of food, constipation and by an excess of industrial foods that
produce endogenous toxins, along with exogenous toxins from the
environment. We found 700 chemicals in drinking water, 3000 chemicals
in food and 10,000 chemicals in processed foods , fertilizers, pesticides
that their use continues to increase.
Colon intoxication from constipation especially in case of prostate cancer
cannot be minimized. According to Dr. Joseph Brenner, Oncologist not
only do people already have already excess of toxins when cancer is first
diagnosed but the amount of toxins increase due to the toxic drugs and the
breakdown of tumors that poison the body which overtax the liver. The
intestinal microbiome , called micro-flora is also critical to increase the
immune defense and today attracts more attention from science especially
today in reference in cancer treatment..
Therefore Dr. Joseph Brenner suggests like I have done for so many years
colon cleansing, diet, and mini fasting. Also you can learn more by
reading my new book, “Health and Disease Begin in the Colon,
Featuring Professor Serge Jurasunas' Natural Medicine”, a 350 page
book with over 100 figures and color photographs with special chapters
about the microbiome, how to detox, healing food, diet, some important
supplements, auto-intoxication of the colon and dramatic clinical cases
(Available on Amazon).
Active Detox
To activate detoxification and reinforce the treatment this is a excellent
formula made from coriander, chorella cell peptide, spinach, green tea,
extract of rosemary, brassica (from broccoli) N-Acetyl Cysteine,
methionine, zinc and selenium which are all important for prostate cancer.
1- Case of earlier prostate cancer (or hypertrophy,higher PSA level)
Prae cell, curcumin,biobran,pomegranate, green propolis, Active Detox.
2- Case of prostate cancer with bone metastases, advanced disease

14. Treatment:
Tegaran, curcumin, Biobran, Prae cell, Active detox. Green propolis
However even with localized prostate cancer patient can take Tegaran if
the PSA is still increasing and combine it with Biobran. There is a
synergistic effect of Biobran with curcumin but also Genistein and
curcuma so it shows that we really have worked with the best
combinations. The advice of a physician is sometimes required and
patients can come to our clinic for a personal consultation or they can have
a consultation by phone, email or Skype for personalized treatment, diet
and nutritional advice. To learn more about prostate cancer as I have said
before read my new article to be published in Townsend Letter, The
Examiner of Alternative medicine (USA) or contact me below:
Dr. Serge Jurasunas explaining the result of a molecular markers testing to a
cancer patient in remission but with high risk of disease recurrence as shown by
the result.
Consultation:

15. phone: 351 912565038
email: sergejurasunas@hotmail.com
Skype: Serge Jurasunas
Blog: Https://naturopathiconcology.blogspot.com.
www. Sergejurasunas.com
Slideshare: www.slideshare.net/SheldonStein